- Home
- CLNN vs PRPO Comparison
CLNN vs PRPO Comparison
Compare CLNN & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- PRPO
- Stock Information
- Founded
- CLNN 2012
- PRPO N/A
- Country
- CLNN United States
- PRPO United States
- Employees
- CLNN N/A
- PRPO N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- CLNN Health Care
- PRPO Industrials
- Exchange
- CLNN Nasdaq
- PRPO Nasdaq
- Market Cap
- CLNN 23.1M
- PRPO 22.0M
- IPO Year
- CLNN N/A
- PRPO N/A
- Fundamental
- Price
- CLNN $3.82
- PRPO $13.80
- Analyst Decision
- CLNN Strong Buy
- PRPO
- Analyst Count
- CLNN 5
- PRPO 0
- Target Price
- CLNN $40.00
- PRPO N/A
- AVG Volume (30 Days)
- CLNN 70.5K
- PRPO 7.2K
- Earning Date
- CLNN 08-19-2025
- PRPO 08-14-2025
- Dividend Yield
- CLNN N/A
- PRPO N/A
- EPS Growth
- CLNN N/A
- PRPO N/A
- EPS
- CLNN N/A
- PRPO N/A
- Revenue
- CLNN $350,000.00
- PRPO $20,029,000.00
- Revenue This Year
- CLNN N/A
- PRPO N/A
- Revenue Next Year
- CLNN $1,753.57
- PRPO N/A
- P/E Ratio
- CLNN N/A
- PRPO N/A
- Revenue Growth
- CLNN N/A
- PRPO 26.67
- 52 Week Low
- CLNN $2.28
- PRPO $3.90
- 52 Week High
- CLNN $6.90
- PRPO $16.89
- Technical
- Relative Strength Index (RSI)
- CLNN 55.42
- PRPO 49.26
- Support Level
- CLNN $3.30
- PRPO $13.92
- Resistance Level
- CLNN $3.93
- PRPO $14.65
- Average True Range (ATR)
- CLNN 0.23
- PRPO 0.38
- MACD
- CLNN 0.02
- PRPO -0.21
- Stochastic Oscillator
- CLNN 82.61
- PRPO 0.00
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.